Dr. Kavanaugh Abstract 1175 (no link) Sweedish study: ETA biosimilar rx habits and prices. Biosimilar usage increases until originator med price drops, then biosimilar usage drops #ACR18 @RheumNow

Dr. Cush ABSTRACT: 2220 Gout, Flares and Allopurinol Use: A Population Based Study. —Australian study, large number of under treated with rate lowering therapy. Also, see abstracts: 1247, 1272. #ACR18 @Rheumnow https://t.co/BJKqxFtuvG

Dr. Kavanaugh ABSTRACT: 404 Interleukin 17A– a Translational Target to Treat Supraspinatus Tendinopathy —found high IL17A in human SS tendinopathy. Then rodent model, IL17A blockade improves tendon structure/function #ACR18 @Rheumnow https://t.co/wa8R9UBplR

Dr. Cush ABSTRACT: 2788 The Effects of Plasma Exchange & Reduced Glucocorticoids during Remission-Induction for Treatment of Severe ANCA-Assoc Vasculitis —PE did not reduce risk of ESRD or death. Lower GC use did not inc death or ESRD #ACR18 @Rheumnow https://t.co/vI0s74b68T

Dr. Kavanaugh ABSTRACT: 2264 Methotrexate in the Treatment of Granulomatous Mastitis: A Retrospective Review of 19 Cases —seen in multiparous Hispanic females, successfully treated with MTX #ACR18 @Rheumnow https://t.co/oGh8x1wgLg

Dr. Cush ABSTRACT: 837 Efficacy of High-Dose Versus Standard-Dose Influenza Vaccine in Seropositive Rheumatoid Arthritis Patients —improved immune response to HD vs. SD for its on DMARDS +/- Biologics (except RTX), no increase Dz activity #ACR18 @Rheumnow https://t.co/pviGwSNeVK

Dr. Cush ABSTRACT: L11 Etanercept & MTX As Monotherapy or in Combination in Patients with Psoriatic Arthritis: A Phase 3, Double-Blind, Randomized Controlled Study —Addition of MTX to ETN did not improve efficacy compared with ETN alone. #ACR18 @Rheumnow https://t.co/6y8OTEVgPB

Great to see our review article, 'The Impact of #Fibromyalgia in #Spondyloarthritis: From Classification Criteria to Outcome Measures' published in @FrontiersIn https://t.co/FjsseFlj0R @alessia_alunno #rheumatology #rheum #dontdelay #connecttoday

Terrific thread increasing your influence #ACR18 —Knowing what your personal&institutional priorities are is a key first step —Understanding culture of different organizations and fields also critical as we work in interdisciplinary teams @LonaMody @LFerranteMD @TideswellUCSF https://t.co/NIPbHpzMBP

#ACR18 Rheum roundup highlights (1): 1) ANCA antibody positivity predict relapse in patients with GBM GN (not that we see a lot of these - mostly nephrologists); 2) SQ Tocilizumab did not improve skin scores, but improved lung function in #scleroderma after 48 weeks

Eric Matteson have a great lecture on the history of cortisone, he really showed what a sensation this discovery was but showed aftermath of the side effects. He was kind enough to give an interview with rheuminations after so stay tuned! #ACR18 #cleclinicrheum @HealioRheum

Eric M. Ruderman, MD: Addressing Safety Issues https://t.co/fm7HWriSIc via @mdmagazine